<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002863'>Myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) comprise a <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> group of <z:e sem="disease" ids="C0018939" disease_type="Disease or Syndrome" abbrv="">hematological diseases</z:e> deriving from a clonally expanded precursor bone marrow cell </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are characterized by ineffective hematopoiesis, peripheral cytopenias of various degrees and increased risk for transformation into <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The incidence is highest in elderly people </plain></SENT>
<SENT sid="3" pm="."><plain>Diagnosis is based on <z:mp ids='MP_0000002'>morphology</z:mp>, exclusion of reactive causes of dyshematopoiesis and cytogenetics/ FISH </plain></SENT>
<SENT sid="4" pm="."><plain>Allogeneic stem cell transplantation, the only curative therapy so far, is not feasible for most of the patients </plain></SENT>
<SENT sid="5" pm="."><plain>Other therapeutic options include supportive therapy such as blood transfusions and antibiotics, hematopoietic growth factors (rHuEPO, G-CSF), immunomodulating agents and chemotherapy </plain></SENT>
<SENT sid="6" pm="."><plain>It is important to install iron chelation therapy in cases with long term transfusion dependency </plain></SENT>
</text></document>